BORTEZOMIB
bortezomib 1 mg injection, 1 vial
BORTEZOMIB (12227M)
12227M
Manner of administration:Injection
Restriction
Indication: Multiple myeloma
Restriction
Indication: Newly diagnosed systemic light chain amyloidosis
Treatment phase: Administration on Days 1, 8, 15 and 22 of six treatment cycles (28 days per cycle)
in total
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 3000 mcg | # of repeats: 15 | DPMA: $111.70 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| BORTEZOMIB EUGIA
(bortezomib 3.5 mg injection, 1 vial)
|
||||
| BORTEZOMIB MEDSURGE
(bortezomib 3.5 mg injection, 1 vial)
|
||||
| BORTRACZO
(bortezomib 2.5 mg/mL injection, 1 mL vial)
|
||||
| BORTRACZO
(bortezomib 3.5 mg/1.4 mL injection, 1.4 mL vial)
|
||||
| Bortezom
(bortezomib 3.5 mg injection, 1 vial)
|
||||
| Bortezomib Accord
(bortezomib 1 mg injection, 1 vial)
|
||||
| Bortezomib Accord
(bortezomib 3.5 mg injection, 1 vial)
|
||||
| Bortezomib Accord
(bortezomib 2.5 mg/mL injection, 1 mL vial)
|
||||
| Bortezomib Accord
(bortezomib 3.5 mg/1.4 mL injection, 1.4 mL vial)
|
||||
| Bortezomib Baxter
(bortezomib 3.5 mg injection, 1 vial)
|
||||
| Bortezomib Ever Pharma
(bortezomib 2.5 mg/mL injection, 1 mL vial)
|
||||
| Bortezomib Ever Pharma
(bortezomib 3.5 mg/1.4 mL injection, 1.4 mL vial)
|
||||
| Bortezomib Juno
(bortezomib 2.5 mg injection, 1 vial)
|
||||
| Bortezomib Juno
(bortezomib 3.5 mg injection, 1 vial)
|
||||
| DBL Bortezomib
(bortezomib 3 mg injection, 1 vial)
|
||||
| DBL Bortezomib
(bortezomib 3.5 mg injection, 1 vial)
|
||||